Our findings showed that NF-ĸB p65 (RELA) but not HIF-1α had four putative binding sites on the promoter of BCL2A1, indicating that NF-κB signaling was the upstream inducer of BCL2A1 in ovarian cancer cells. Here, HIF1A is linked to ovarian carcinoma.